Anal cancer
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Synonyms and keywords:: Carcinoma of the anus; Anal carcinoma;
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Anal cancer is a type of cancer which arises from the anus, the distal orifice of the gastrointestinal tract. It is a distinct entity from the more common colorectal cancer. The etiology, risk factors, clinical progression, staging, and treatment are all different. Anal cancer is typically a squamous cell carcinoma that arises near the squamocolumnar junction and its often linked to human papillomavirus (HPV) infection. It may be keratinizing (basaloid) or non-keratinizing (cloacogenic). Other types of anal cancer are adenocarcinoma, lymphoma, sarcoma or melanoma. Treatment depends on the stage of the disease at the time of diagnosis.
Classification
Anal cancer may be classified according to histology into four subtypes: squamous cell carcinoma, adenocarcinoma, lymphoma, and sarcoma.
Pathophysiology
Anal cancer most commonly arises from squamous cells at the squamocolumnar junction. Other types of anal cancer are adenocarcinoma, lymphoma, and sarcoma.
Epidemiology and Demographics
In 2008-2012, the incidence of anal cancer was estimated to be 1.8 cases per 100,000 individuals in the US.
Risk Factor
The most potent risk factor in the development of anal cancer is Human Papillomavirus (HPV). Other risk factors include receptive anal intercourse with multiple sexual partners, smoking, and immunosuppression.
Screening
Screening for anal cancer by pap smear is suggested among HIV-positive patients and homosexual men.
Causes
Squamous carcinoma of the anus may be caused by HPV infection.
Differential Diagnosis
Anal cancer must be differentiated from other diseases that cause anal pain, anal pressure, and hematochezia, such as, anal fissure, and neoplastic ulcers.
Natural History, Complication, and Prognosis
Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. The three major prognostic factors are site (anal canal vs. perianal skin), size (primary tumors <2 cm in size have better prognoses), and lymph nodes involvement.[1]
Staging
The staging of Anal cancer is based on the TNM staging system [1]
History and Symptoms
Symptoms of anal cancer include pain or pressure in the anus or rectum, anal itching and anal discharge.
Physical Examination
Common physical examination findings of anal cancer include a lump near the anus and rectal bleeding.
Diagnostic Studies
Laboratory Studies
There are no diagnostic lab findings associated with anal cancer.
MRI
Pelvic MRI may be diagnostic of anal cancer.
CT
CT may be helpful in the diagnosis and staging of anal cancer.
Ultrasound
Endoanal ultrasound may be helpful in the diagnosis, staging, determination of the depth of penetration, and to monitor the response to chemo and/or radiation therapy to anal cancer.
Other Imaging Studies
PET–CT may be helpful in anal cancer staging.[2]
Other Diagnostic Imaging
Anoscopy, proctoscopy, and biopsy maybe helpful in the diagnosis of anal cancer.
Medical Therapy
The predominant therapy for anal cancer is chemotherapy and radiation.
Surgery
Surgical resection is not recommended among patients with advanced or metastatic anal cancer.
Primary Prevention
HPV vaccine is recommended for homosexual men, bisexual men, and women who engage in receptive anal sex to prevent anal cancer. Other primary prevention strategies include smoking cessation and condom use.[1]
References
- ↑ 1.0 1.1 1.2 National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/anal/hp/anal-treatment-pdq
- ↑ http://radiopaedia.org/articles/anal-cancer
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Anal cancer may be classified according to histology into four subtypes: squamous cell carcinoma, adenocarcinoma, lymphoma, and sarcoma.
Classification
Anal cancer is classified to:
- Squamous cell carcinoma
- Adenocarcinoma
- Lymphoma
- Sarcoma
References
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Anal cancer most commonly arises from squamous cells at the squamocolumnar junction. Other types of anal cancer are adenocarcinoma, lymphoma, and sarcoma.
Microscopic Pathology
Common types of anal cancers are:
- Squamous cell carcinoma
- Adenocarcinoma
- Lymphoma
- Sarcoma
References
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
overview
Squamous carcinoma of the anus may be caused by HPV infection[1]
References
- ↑ National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/anal/hp/anal-prevention-pdq
Differentiating Anal cancer from other Disorders
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Anal cancer must be differentiated from other diseases that cause anal pain, anal pressure, and hematochezia, such as, anal fissure and neoplastic ulcers.
Differential diagnosis
Anal cancer must be differentiated from other diseases that cause anal discomfort and pain with defecation such as hemorrhoids, anal fissure and perianal abscess.
| Disease | History | Physical exam findings | Sample image |
|---|---|---|---|
| Hemorrhoids |
External hemorrhoids
Internal hemorrhoids
|
Skin examination
Digital rectal examination
|
![]() |
| Anal fissure |
|
|
![]() |
| Rectal prolapse |
|
|
![]() |
| Perianal abscess |
|
|
|
| Anal cancer |
|
![]() | |
| Condylomata acuminata |
|
|
References
- ↑ Schlichtemeier S, Engel A (2016). “Anal fissure”. Aust Prescr. 39 (1): 14–7. doi:10.18773/austprescr.2016.007. PMC 4816871. PMID 27041801.
- ↑ Beaty JS, Shashidharan M (2016). “Anal Fissure”. Clin Colon Rectal Surg. 29 (1): 30–7. doi:10.1055/s-0035-1570390. PMC 4755763. PMID 26929749.
- ↑ Cannon JA (2017). “Evaluation, Diagnosis, and Medical Management of Rectal Prolapse”. Clin Colon Rectal Surg. 30 (1): 16–21. doi:10.1055/s-0036-1593431. PMID 28144208.
- ↑ Blaker K, Anandam JL (2017). “Functional Disorders: Rectoanal Intussusception”. Clin Colon Rectal Surg. 30 (1): 5–11. doi:10.1055/s-0036-1593433. PMID 28144206.
- ↑ Sahnan K, Adegbola SO, Tozer PJ, Watfah J, Phillips RK (2017). “Perianal abscess”. BMJ. 356: j475. PMID 28223268.
- ↑ Moureau-Zabotto L, Vendrely V, Abramowitz L, Borg C, Francois E, Goere D, Huguet F, Peiffert D, Siproudhis L, Ducreux M, Bouché O (2017). “Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up”. Dig Liver Dis. doi:10.1016/j.dld.2017.05.011. PMID 28610905.
- ↑ Prigge ES, von Knebel Doeberitz M, Reuschenbach M (2017). “Clinical relevance and implications of HPV-induced neoplasia in different anatomical locations”. Mutat. Res. 772: 51–66. doi:10.1016/j.mrrev.2016.06.005. PMID 28528690.
- ↑ Wieland U, Kreuter A (2017). “[Genital warts in HIV-infected individuals]”. Hautarzt (in German). 68 (3): 192–198. doi:10.1007/s00105-017-3938-z. PMID 28160045.
- ↑ Köhn FM, Schultheiss D, Krämer-Schultheiss K (2016). “[Dermatological diseases of the external male genitalia : Part 2: Infectious and malignant dermatological]”. Urologe A (in German). 55 (7): 981–96. doi:10.1007/s00120-016-0163-9. PMID 27364818.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [3]
Overview
In 2008-2012, the incidence of anal cancer was estimated to be 1.8 cases per 100,000 individuals in the US.
Epidemiology
Incidence[1]
- In women and men who do not engage in anal intercourse with other men – 0.9/100,000
- In HIV negative men who engage in anal intercourse with other men – 35/100,000
- In HIV positive men who engage in anal intercourse with other men – (estimated) 60-70/100,000
- Number of New Cases and Deaths per 100,000: The number of new cases of anal cancer was 1.8 per 100,000 men and women per year. The number of deaths was 0.2 per 100,000 men and women per year. These rates are age-adjusted and based on 2008-2012 cases and deaths.
- Lifetime Risk of Developing Cancer: Approximately 0.2 percent of men and women will be diagnosed with anal cancer at some point during their lifetime, based on 2010-2012 data.[2]
- Because it is rare and because it occurs in a body part that is rarely discussed, most people are unaware of its existence.
- An examination of squamous cell carcinoma tumor tissues from patients in Denmark and Sweden showed a high proportion of anal cancers to be positive for the types of HPV that are also associated with high risk of cervical cancer (90% of the tumors from women, 100% of the tumors from homosexual men, and 58% of tumors from heterosexual men).[3]
References
- ↑ Anal Carcinoma [1]
- ↑ National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015.http://seer.cancer.gov/statfacts/html/anus.html
- ↑ Danish Medical Bulletin. 2002 Aug;49(3):194-209
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
The most potent risk factor in the development of anal cancer is Human Papillomavirus (HPV). Other risk factors include receptive anal intercourse with multiple sexual partners, smoking, and immunosuppression.
Common Risk Factors
Common risk factors associated with anal cancer are:
- Human papillomavirus (HPV) infection, notably HPV-16.[1]
- Sexual activity: Having multiple sex partners or having anal sex, due to the increased risk of exposure to the HPV virus.[2]
- Smoking: Current smokers are several times more likely to develop anal cancer compared with nonsmokers.[2]
- Immunosuppression, which is often associated with HIV infection.[2]
- Being older than 50 years [3]
- Frequent anal redness, swelling, and soreness [3]
- Having anal fistulas (abnormal openings) [3]
References
- ↑ New England Journal of Medicine. 1997 Nov 6;337(19):1350-8
- ↑ 2.0 2.1 2.2 American Cancer Society.“What Are the Risk Factors for Anal Cancer?”
- ↑ 3.0 3.1 3.2 National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/types/anal/patient/anal-treatment-pdq
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Screening for anal cancer by pap smear is suggested among HIV-positive patients and homosexual men.
Screening
Anal pap smears similar to those used in cervical cancer screening have been studied experimentally for early detection of anal cancer in high-risk individuals.[1][2]
References
- ↑ Cichoki, Mark. “Anal Papilloma Screening” on About.com
- ↑ Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag H (2006). “Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review”. Clin. Infect. Dis. 43 (2): 223–33. doi:10.1086/505219. PMID 16779751.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. The three major prognostic factors are site (anal canal vs. perianal skin), size (primary tumors <2 cm in size have better prognoses), and lymph nodes involvement.[1]
Prognosis
The prognosis of anal cancer depends on the following:[1]
- Size of tumor
- Location of anal cancer in the anus
- Spread to the lymph nodes
References
- ↑ 1.0 1.1 National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/anal/hp/anal-treatment-pdq
Diagnosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | MRI | CT | Ultrasound | Other imaging findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
References
References
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH




